MedTrace Logo

Immune Responses to Dengue and Sepsis

NCT07040202 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2025-06-27

No results posted yet for this study

Summary

The goal of this research study is to help the investigators better understand serious dengue disease. The investigators will collect clinical information and up to four blood samples from participants with dengue, sepsis, or healthy people. The investigators will perform multiple analyses on the blood samples and compare results between dengue patients and those with sepsis and healthy people.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Institut Pasteur du Cambodge

    lead OTHER

Principal Investigators

  • Tineke Cantaert, PhD · Institut Pasteur du Cambodge

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-02
Primary Completion
2025-11-30
Completion
2026-12-31

Countries

  • Cambodia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07040202 on ClinicalTrials.gov